BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Manjaly ZM, Harrison NA, Critchley HD, Do CT, Stefanics G, Wenderoth N, Lutterotti A, Müller A, Stephan KE. Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis. J Neurol Neurosurg Psychiatry 2019;90:642-51. [PMID: 30683707 DOI: 10.1136/jnnp-2018-320050] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 18.3] [Reference Citation Analysis]
Number Citing Articles
1 Siciliano M, De Micco R, Trojano L, Sant'Elia V, Giordano A, Russo A, Passamonti L, Tedeschi G, Chiorri C, Tessitore A. The psychological correlates of fatigue in Parkinson's disease: Contribution of maladaptive metacognitive beliefs. Parkinsonism Relat Disord 2021;91:135-8. [PMID: 34607090 DOI: 10.1016/j.parkreldis.2021.09.020] [Reference Citation Analysis]
2 Bächinger M, Lehner R, Thomas F, Hanimann S, Balsters J, Wenderoth N. Human motor fatigability as evoked by repetitive movements results from a gradual breakdown of surround inhibition. Elife 2019;8:e46750. [PMID: 31524600 DOI: 10.7554/eLife.46750] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 Thompson AJ, Carroll W, Ciccarelli O, Comi G, Cross A, Donnelly A, Feinstein A, Fox RJ, Helme A, Hohlfeld R, Hyde R, Kanellis P, Landsman D, Lubetzki C, Marrie RA, Morahan J, Montalban X, Musch B, Rawlings S, Salvetti M, Sellebjerg F, Sincock C, Smith KE, Strum J, Zaratin P, Coetzee T. Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal. Mult Scler 2022;28:16-28. [PMID: 34850641 DOI: 10.1177/13524585211059766] [Reference Citation Analysis]
4 Al-zubaidi A, Iglesias S, Stephan KE, Buades-rotger M, Heldmann M, Nolde JM, Kirchner H, Mertins A, Jauch-chara K, Münte TF. Effects of hunger, satiety and oral glucose on effective connectivity between hypothalamus and insular cortex. NeuroImage 2020;217:116931. [DOI: 10.1016/j.neuroimage.2020.116931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
5 Carandini T, Mancini M, Bogdan I, Rae CL, Barritt AW, Sethi A, Harrison N, Rashid W, Scarpini E, Galimberti D, Bozzali M, Cercignani M. Disruption of brainstem monoaminergic fibre tracts in multiple sclerosis as a putative mechanism for cognitive fatigue: a fixel-based analysis. Neuroimage Clin 2021;30:102587. [PMID: 33610097 DOI: 10.1016/j.nicl.2021.102587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Manjaly ZM, Iglesias S. A Computational Theory of Mindfulness Based Cognitive Therapy from the "Bayesian Brain" Perspective. Front Psychiatry 2020;11:404. [PMID: 32499726 DOI: 10.3389/fpsyt.2020.00404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Dacosta-aguayo R, Wylie G, Deluca J, Genova H, Trojano L. Anatomical Covariance Analysis: Detection of Disrupted Correlation Network Related to Clinical Trait Fatigue in Multiple Sclerosis: A Pilot Study. Behavioural Neurology 2020;2020:1-9. [DOI: 10.1155/2020/5807496] [Reference Citation Analysis]
8 Alawami AS, Abdulla FA. Psychometric properties of an Arabic translation of the modified fatigue impact scale in patients with multiple sclerosis. Disability and Rehabilitation. [DOI: 10.1080/09638288.2020.1731853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Akaishi T, Takahashi T, Fujihara K, Misu T, Fujimori J, Takai Y, Nishiyama S, Abe M, Ishii T, Aoki M, Nakashima I. Early Treatment Initiation With Oral Prednisolone for Relapse Prevention Alleviates Depression and Fatigue in Aquaporin-4-Positive Neuromyelitis optica Spectrum Disorder. Front Neurol 2021;12:608149. [PMID: 33692739 DOI: 10.3389/fneur.2021.608149] [Reference Citation Analysis]
10 Walker CS, Berard JA, Walker LAS. Validation of Discrete and Regression-Based Performance and Cognitive Fatigability Normative Data for the Paced Auditory Serial Addition Test in Multiple Sclerosis. Front Neurosci 2021;15:730817. [PMID: 34867152 DOI: 10.3389/fnins.2021.730817] [Reference Citation Analysis]
11 Redlicka J, Zielińska-Nowak E, Lipert A, Miller E. Impact of Moderate Individually Tailored Physical Activity in Multiple Sclerosis Patients with Fatigue on Functional, Cognitive, Emotional State, and Postural Stability. Brain Sci 2021;11:1214. [PMID: 34573235 DOI: 10.3390/brainsci11091214] [Reference Citation Analysis]
12 Couvineau A, Voisin T, Nicole P, Gratio V, Blais A. Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions. World J Gastroenterol 2021; 27(44): 7582-7596 [PMID: 34908800 DOI: 10.3748/wjg.v27.i44.7582] [Reference Citation Analysis]
13 Yang X, Li F, Liu Y, Li D, Li J. Study on the Correlation Between NF-κB and Central Fatigue. J Mol Neurosci 2021;71:1975-86. [PMID: 33586033 DOI: 10.1007/s12031-021-01803-z] [Reference Citation Analysis]
14 Saberi A, Abdolalizadeh A, Mohammadi E, Nahayati MA, Bagheri H, Shekarchi B, Kargar J. Thalamic shape abnormalities in patients with multiple sclerosis-related fatigue. Neuroreport 2021;32:438-42. [PMID: 33788816 DOI: 10.1097/WNR.0000000000001616] [Reference Citation Analysis]
15 Czarnowska A, Kapica-Topczewska K, Zajkowska O, Adamczyk-Sowa M, Kubicka-Bączyk K, Niedziela N, Warmus P, Kalinowska-Łyszczarz A, Kania K, Słowik A, Wnuk M, Marona M, Nowak K, Bartosik-Psujek H, Lech B, Perenc A, Popiel M, Kucharska-Lipowska M, Chorąży M, Tarasiuk J, Mirończuk A, Kochanowicz J, Lasek-Bal A, Puz P, Maciejowska K, Wawrzyniak S, Niezgodzińska-Maciejek A, Pokryszko-Dragan A, Gruszka E, Budrewicz S, Białek M, Zwiernik J, Michałowska A, Nosek K, Zwiernik B, Lewańczyk B, Brola W, Kułakowska A. Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland. J Clin Med 2021;10:5225. [PMID: 34830507 DOI: 10.3390/jcm10225225] [Reference Citation Analysis]
16 Sandi D, Fricska-Nagy Z, Bencsik K, Vécsei L. Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players. Molecules 2021;26:3423. [PMID: 34198750 DOI: 10.3390/molecules26113423] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Veldhuijzen van Zanten J, Douglas MR, Ntoumanis N. Fatigue and fluctuations in physical and psychological wellbeing in people with multiple sclerosis: A longitudinal study. Mult Scler Relat Disord 2021;47:102602. [PMID: 33176231 DOI: 10.1016/j.msard.2020.102602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Siciliano M, De Micco R, Giordano A, Di Nardo F, Russo A, Caiazzo G, De Mase A, Cirillo M, Tedeschi G, Trojano L, Tessitore A. Supplementary motor area functional connectivity in “drug-naïve” Parkinson’s disease patients with fatigue. J Neural Transm 2020;127:1133-42. [DOI: 10.1007/s00702-020-02219-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Tommasin S, De Luca F, Ferrante I, Gurreri F, Castelli L, Ruggieri S, Prosperini L, Pantano P, Pozzilli C, De Giglio L. Cognitive fatigability is a quantifiable distinct phenomenon in multiple sclerosis. J Neuropsychol 2020;14:370-83. [PMID: 31729168 DOI: 10.1111/jnp.12197] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Kallmann BA, Ries S, Kullmann JS, Quint LM, Engelmann U, Chan A. Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment status. Ther Adv Neurol Disord 2021;14:17562864211005588. [PMID: 34046085 DOI: 10.1177/17562864211005588] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Agostini F, Pezzi L, Paoloni M, Insabella R, Attanasi C, Bernetti A, Saggini R, Mangone M, Paolucci T. Motor Imagery: A Resource in the Fatigue Rehabilitation for Return-to-Work in Multiple Sclerosis Patients-A Mini Systematic Review. Front Neurol 2021;12:696276. [PMID: 34290665 DOI: 10.3389/fneur.2021.696276] [Reference Citation Analysis]
22 García-Muñoz C, Casuso-Holgado MJ, Hernández-Rodríguez JC, Pinero-Pinto E, Palomo-Carrión R, Cortés-Vega MD. Feasibility and safety of an immersive virtual reality-based vestibular rehabilitation programme in people with multiple sclerosis experiencing vestibular impairment: a protocol for a pilot randomised controlled trial. BMJ Open 2021;11:e051478. [PMID: 34810187 DOI: 10.1136/bmjopen-2021-051478] [Reference Citation Analysis]
23 Kuppuswamy A. The Neurobiology of Pathological Fatigue: New Models, New Questions. Neuroscientist 2021;:1073858420985447. [PMID: 33446049 DOI: 10.1177/1073858420985447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Daunoraviciene K, Ziziene J, Ovcinikova A, Kizlaitiene R, Griskevicius J. Quantitative body symmetry assessment during neurological examination. Technol Health Care 2020;28:573-84. [PMID: 32831213 DOI: 10.3233/THC-208003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Proschinger S, Joisten N, Rademacher A, Schlagheck ML, Walzik D, Metcalfe AJ, Oberste M, Warnke C, Bloch W, Schenk A, Bansi J, Zimmer P. Influence of combined functional resistance and endurance exercise over 12 weeks on matrix metalloproteinase-2 serum concentration in persons with relapsing-remitting multiple sclerosis - a community-based randomized controlled trial. BMC Neurol 2019;19:314. [PMID: 31810462 DOI: 10.1186/s12883-019-1544-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
26 Melnikov M, Pashenkov M, Boyko A. Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential? Int J Mol Sci 2021;22:5313. [PMID: 34070011 DOI: 10.3390/ijms22105313] [Reference Citation Analysis]
27 Norton J, Joos S, Cameron MH, Hugos CL. A multisite randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Very long term (5-6 year) follow-up at one site. Mult Scler J Exp Transl Clin 2021;7:20552173211054454. [PMID: 34868627 DOI: 10.1177/20552173211054454] [Reference Citation Analysis]
28 Ma C, Deng Y, Xiao R, Xu F, Li M, Gong Q, Gao J. Anti-fatigue effect of phlorizin on exhaustive exercise-induced oxidative injury mediated by Nrf2/ARE signaling pathway in mice. Eur J Pharmacol 2021;:174563. [PMID: 34942162 DOI: 10.1016/j.ejphar.2021.174563] [Reference Citation Analysis]
29 Liu S, Cheng Y, Chen WZ, Lv JX, Zheng BS, Huang DD, Xia XF, Yu Z. Inflammation Disturbed the Tryptophan Catabolites in Hippocampus of Post-operative Fatigue Syndrome Rats via Indoleamine 2,3-Dioxygenas Enzyme and the Improvement Effect of Ginsenoside Rb1. Front Neurosci 2021;15:652817. [PMID: 34512234 DOI: 10.3389/fnins.2021.652817] [Reference Citation Analysis]
30 Zackowski KM, Freeman J, Brichetto G, Centonze D, Dalgas U, DeLuca J, Ehde D, Elgott S, Fanning V, Feys P, Finlayson M, Gold SM, Inglese M, Marrie RA, Ploughman M, Sang CN, Sastre-Garriga J, Sincock C, Strum J, van Beek J, Feinstein A. Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance. Mult Scler 2021;27:989-1001. [PMID: 33720795 DOI: 10.1177/1352458521999970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Bradley L. Delayed amantadine toxicity causing apparent progression of multiple sclerosis. Mult Scler 2021;27:2288-90. [PMID: 34486465 DOI: 10.1177/13524585211035737] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Pallais JP, Kotz CM, Stanojlovic M. Orexin/hypocretinin in multiple sclerosis and experimental autoimmune encephalomyelitis. Neural Regen Res 2020;15:1039-40. [PMID: 31823881 DOI: 10.4103/1673-5374.270310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Nourbakhsh B, Waubant E, Evers AWM, Solomon AJ. Ethical considerations in the treatment of multiple sclerosis fatigue. Mult Scler Relat Disord 2021;54:103129. [PMID: 34247106 DOI: 10.1016/j.msard.2021.103129] [Reference Citation Analysis]
34 Heitmann H, Andlauer TFM, Korn T, Mühlau M, Henningsen P, Hemmer B, Ploner M. Fatigue, depression, and pain in multiple sclerosis: How neuroinflammation translates into dysfunctional reward processing and anhedonic symptoms. Mult Scler 2020;:1352458520972279. [PMID: 33179588 DOI: 10.1177/1352458520972279] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Cercignani M, Dipasquale O, Bogdan I, Carandini T, Scott J, Rashid W, Sabri O, Hesse S, Rullmann M, Lopiano L, Veronese M, Martins D, Bozzali M. Cognitive fatigue in multiple sclerosis is associated with alterations in the functional connectivity of monoamine circuits. Brain Commun 2021;3:fcab023. [PMID: 33842886 DOI: 10.1093/braincomms/fcab023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Carandini T, Cercignani M, Galimberti D, Scarpini E, Bozzali M. The distinct roles of monoamines in multiple sclerosis: A bridge between the immune and nervous systems? Brain Behav Immun 2021;94:381-91. [PMID: 33662501 DOI: 10.1016/j.bbi.2021.02.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
37 Lakin L, Davis BE, Binns CC, Currie KM, Rensel MR. Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms-A Narrative Review. Neurol Ther 2021;10:75-98. [PMID: 33877583 DOI: 10.1007/s40120-021-00239-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
38 Gonzalez Campo C, Salamone PC, Rodríguez-Arriagada N, Richter F, Herrera E, Bruno D, Pagani Cassara F, Sinay V, García AM, Ibáñez A, Sedeño L. Fatigue in multiple sclerosis is associated with multimodal interoceptive abnormalities. Mult Scler 2020;26:1845-53. [PMID: 31778101 DOI: 10.1177/1352458519888881] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
39 Matesic I, Marcinko I. Identifying the relevant determinants of MS related fatigue: The role of the clinical indicators of disease and personality. Mult Scler Relat Disord 2020;42:102054. [PMID: 32213466 DOI: 10.1016/j.msard.2020.102054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Kruglikov IL, Joffin N, Scherer PE. The MMP14–caveolin axis and its potential relevance for lipoedema. Nat Rev Endocrinol 2020;16:669-74. [DOI: 10.1038/s41574-020-0395-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
41 Diaz-Arias LA, Yeshokumar AK, Glassberg B, Sumowski JF, Easton A, Probasco JC, Venkatesan A. Fatigue in Survivors of Autoimmune Encephalitis. Neurol Neuroimmunol Neuroinflamm 2021;8:e1064. [PMID: 34389660 DOI: 10.1212/NXI.0000000000001064] [Reference Citation Analysis]
42 Enoka RM, Almuklass AM, Alenazy M, Alvarez E, Duchateau J. Distinguishing between Fatigue and Fatigability in Multiple Sclerosis. Neurorehabil Neural Repair 2021;35:960-73. [PMID: 34583577 DOI: 10.1177/15459683211046257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Abdulla FA, Albagmi FM, Al-Khamis FA. Factors that influence quality of life in patients with multiple sclerosis in Saudi Arabia. Disabil Rehabil 2021;:1-9. [PMID: 33966564 DOI: 10.1080/09638288.2021.1919929] [Reference Citation Analysis]
44 Ysrraelit MC, Fiol MP, Peña FV, Vanotti S, Terrasa SA, Tran VT, Montori VM, Correale J. Adaptation and validation of a Spanish version of the treatment burden questionnaire in patients with multiple sclerosis. BMC Neurol 2019;19:209. [PMID: 31455235 DOI: 10.1186/s12883-019-1441-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 García-Muñoz C, Cortés-Vega MD, Heredia-Rizo AM, Martín-Valero R, García-Bernal MI, Casuso-Holgado MJ. Effectiveness of Vestibular Training for Balance and Dizziness Rehabilitation in People with Multiple Sclerosis: A Systematic Review and Meta-Analysis. J Clin Med 2020;9:E590. [PMID: 32098162 DOI: 10.3390/jcm9020590] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
46 Greenhouse-Tucknott A, Wrightson JG, Raynsford M, Harrison NA, Dekerle J. Interactions between perceptions of fatigue, effort, and affect decrease knee extensor endurance performance following upper body motor activity, independent of changes in neuromuscular function. Psychophysiology 2020;57:e13602. [PMID: 32578885 DOI: 10.1111/psyp.13602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Coates KD, Aboodarda SJ, Krüger RL, Martin T, Metz LM, Jarvis SE, Millet GY. Multiple sclerosis-related fatigue: the role of impaired corticospinal responses and heightened exercise fatigability. J Neurophysiol 2020;124:1131-43. [PMID: 32877296 DOI: 10.1152/jn.00165.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
48 Chard DT, Alahmadi AAS, Audoin B, Charalambous T, Enzinger C, Hulst HE, Rocca MA, Rovira À, Sastre-Garriga J, Schoonheim MM, Tijms B, Tur C, Gandini Wheeler-Kingshott CAM, Wink AM, Ciccarelli O, Barkhof F; MAGNIMS Study Group. Mind the gap: from neurons to networks to outcomes in multiple sclerosis. Nat Rev Neurol 2021;17:173-84. [PMID: 33437067 DOI: 10.1038/s41582-020-00439-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
49 Unal O, Eren OC, Alkan G, Petzschner FH, Yao Y, Stephan KE. Inference on homeostatic belief precision. Biol Psychol 2021;165:108190. [PMID: 34547398 DOI: 10.1016/j.biopsycho.2021.108190] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Jiang J, Chu C, Wu C, Wang C, Zhang C, Li T, Zhai Q, Yu L, Tian F, Chen W. Efficacy of probiotics in multiple sclerosis: a systematic review of preclinical trials and meta-analysis of randomized controlled trials. Food Funct 2021;12:2354-77. [DOI: 10.1039/d0fo03203d] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
51 Zrzavy T, Pfitzner A, Flachenecker P, Rommer P, Zettl UK. Effects of normobaric hypoxic endurance training on fatigue in patients with multiple sclerosis: a randomized prospective pilot study. J Neurol 2021. [PMID: 34003370 DOI: 10.1007/s00415-021-10596-5] [Reference Citation Analysis]
52 Bonaz B, Lane RD, Oshinsky ML, Kenny PJ, Sinha R, Mayer EA, Critchley HD. Diseases, Disorders, and Comorbidities of Interoception. Trends Neurosci 2021;44:39-51. [PMID: 33378656 DOI: 10.1016/j.tins.2020.09.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
53 Stamoula E, Siafis S, Dardalas I, Ainatzoglou A, Matsas A, Athanasiadis T, Sardeli C, Stamoulas K, Papazisis G. Antidepressants on Multiple Sclerosis: A Review of In Vitro and In Vivo Models. Front Immunol 2021;12:677879. [PMID: 34093579 DOI: 10.3389/fimmu.2021.677879] [Reference Citation Analysis]
54 Rodgers S, Manjaly ZM, Calabrese P, Steinemann N, Kaufmann M, Salmen A, Chan A, Kesselring J, Kamm CP, Kuhle J, Zecca C, Gobbi C, von Wyl V, Ajdacic-Gross V. The Effect of Depression on Health-Related Quality of Life Is Mediated by Fatigue in Persons with Multiple Sclerosis. Brain Sci 2021;11:751. [PMID: 34198920 DOI: 10.3390/brainsci11060751] [Reference Citation Analysis]
55 Hämäläinen P, Leo V, Therman S, Ruutiainen J. Validation of the Finnish version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and evaluation of the applicability of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) and the Fatigue Scale for Motor and Cognitive Functions (FSMC). Brain Behav 2021;11:e02087. [PMID: 33960700 DOI: 10.1002/brb3.2087] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Tijhuis FB, Broeders TAA, Santos FAN, Schoonheim MM, Killestein J, Leurs CE, van Geest Q, Steenwijk MD, Geurts JJG, Hulst HE, Douw L. Dynamic functional connectivity as a neural correlate of fatigue in multiple sclerosis. Neuroimage Clin 2021;29:102556. [PMID: 33472144 DOI: 10.1016/j.nicl.2020.102556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Carandini T, Mancini M, Bogdan I, Rae CL, Barritt AW, Clerico M, Sethi A, Harrison N, Rashid W, Scarpini E, Galimberti D, Bozzali M, Cercignani M. In vivo evidence of functional disconnection between brainstem monoaminergic nuclei and brain networks in multiple sclerosis. Mult Scler Relat Disord 2021;56:103224. [PMID: 34461571 DOI: 10.1016/j.msard.2021.103224] [Reference Citation Analysis]